Current Concepts in the Diagnosis and Management of Metabolic Complications of HIV Infection and Its Therapy
Open Access
- 1 September 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 43 (5) , 645-653
- https://doi.org/10.1086/507333
Abstract
Changes in fat distribution, dyslipidemia, disordered glucose metabolism, and lactic acidosis have emerged as significant challenges to the treatmentKeywords
This publication has 55 references indexed in Scilit:
- Bone Disease and HIV InfectionClinical Infectious Diseases, 2006
- Standards of Medical Care in DiabetesDiabetes Care, 2005
- Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1PLoS Medicine, 2004
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004
- Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL StudyClinical Infectious Diseases, 2004
- Safety and efficacy of switching to alternative nucleoside analogues following symptomatic hyperlactatemia and lactic acidosisAIDS, 2003
- Lactic acidosis in HIV infected patients: a systematic review of published casesSexually Transmitted Infections, 2003
- Switching Effective Antiretroviral Therapy: A ReviewClinical Infectious Diseases, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophyThe Lancet, 1999